Bolding & Bruggeman ApS
Private limited companyCVR 31072204AsperupActive
Bolding & Bruggeman ApS is a private limited company, based in Asperup, active in research and experimental development on natural sciences and engineering, founded in 2007. Net profit rose 254% from 2024 to 2025, ending at DKK 408k. Profit has grown three years in a row. Equity grew to DKK 1.2m in 2025.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit rose 53% (2024 → 2025), to DKK 2.8m.
- Net profit rose 254% (2024 → 2025), to DKK 408k.
- Equity rose 49% (2024 → 2025), to DKK 1.2m.
Registrations, last 24 months
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 452 | 990 | 970 | 1,713 | 1,828 | 2,798 | +53.1% |
| Operating profit (EBIT) | −306 | 152 | 37 | 65 | 143 | 518 | +263.2% |
| Profit before tax | −316 | 142 | 33 | 69 | 148 | 523 | +254% |
| Net profit | −247 | 111 | 26 | 54 | 115 | 408 | +254% |
| Total assets | 893 | 1,468 | 1,117 | 1,669 | 3,574 | 2,255 | −36.9% |
| Equity | 566 | 677 | 668 | 722 | 837 | 1,244 | +48.7% |
| Liabilities | 327 | 791 | 444 | 947 | 2,737 | 1,011 | −63.1% |
| Cash and cash equivalents | 502 | 1,068 | 929 | 1,535 | 3,456 | 1,713 | −50.4% |
| Average number of employees | 1 | 1 | 1 | 2 | 2 | 0 | −100% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresProfit for five years in a row
Net result has been positive in 2021–2025.
How is this calculated?
Net result is positive in the five latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 29/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 28/05/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 25/06/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 26/06/2023 | The company | PDFXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 28/06/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 11/05/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 24,071of 69,742 Better than 65% | No. 30,725of 69,964 Better than 56% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 74of 323 Better than 77% | No. 145of 329 Better than 56% |
| Companies that are between 15 and 29 years old24,910 companies in the comparison | No. 13,479of 24,791 Better than 46% | No. 17,071of 24,909 Better than 31% |
| All companies of type ApS66,508 companies in the comparison | No. 23,663of 66,379 Better than 64% | No. 26,667of 66,505 Better than 60% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Bolding & Bruggeman ApSDKK 2.8m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Bolding & Bruggeman ApSDKK 408k
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Bolding & Bruggeman ApSDKK 1.2m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Bolding & Bruggeman ApS2
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Bolding Holding ApS50%
- Jorn Bruggeman33.33%
Management
2 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Karsten Bolding | Director | 27/11/2007 |
| Jorn Bruggeman | Director | 09/08/2024 |
- Founders
- Karsten Bolding
Signing rule: Selskabet tegnes af 1 medlem af direktionen.
Address and production units
1 active production unitsStrandgyden 25
5466 Asperup
| Production unit | Address | Employees | P number |
|---|---|---|---|
| BOLDING & BRUGGEMAN ApS | Strandgyden 25, Baaring Mark, 5466 Asperup | 2 | 1013809263 |
Purpose
Selskabets formål er forsknings- og udviklingsvirksomhed indenfor numeriske modeller samt dermed beslægtet virksomhed.
The purpose is quoted from the register in Danish.
Changes year by year
15 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20252 changesaccounts 1 · industry 1
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20242 changesmanagement 1 · accounts 1
- ManagementJorn Bruggeman appointed director
- AccountsAnnual report for 2023 published
20231 changeaccounts 1
- AccountsAnnual report for 2022 published
20221 changeaccounts 1
- AccountsAnnual report for 2021 published
20211 changeaccounts 1
- AccountsAnnual report for 2020 published
20161 changeaddress 1
- AddressMoved to Strandgyden 25, Baaring Mark, 5466 Asperup
20143 changesname 1 · ownership 2
- NameName changed from BOLDING & BURCHARD ApS to BOLDING & BRUGGEMAN ApS
- OwnershipBOLDING HOLDING ApS registered as owner (50%)
- OwnershipJorn Bruggeman registered as owner (33.33%)
20081 changeindustry 1
- IndustryIndustry changed to Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900)
20072 changesfounded 1 · management 1
- FoundedRegistered as BOLDING & BURCHARD ApS
- ManagementKarsten Bolding appointed director
Related companies
Same industry in Middelfart
- Agrolab Field A/S12 employees
- Trinity Synergies A/S7 employees
- Crimarec ApS2 employees
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.